Treatment Discontinuation Following Bariatric Surgery in Obstructive Sleep Apnea: a Controlled Cohort Study

Obesity Surgery
Claire AgostaAnne-Laure Borel

Abstract

Uncontrolled studies looking at the discontinuation of obstructive sleep apnea (OSA) treatment after bariatric surgery (BS) have suggested that surgery improves OSA. However, this discontinuation of OSA treatment by BS patients has never been compared to a matched population without BS. The objectives of this study are to evaluate whether BS increases OSA treatment discontinuation compared to that in matched patients without BS and to identify predictive factors of OSA treatment discontinuation in BS patients. The study took place in an ambulatory, tertiary hospital. We included 61 OSA patients who underwent BS in a retrospective controlled cohort study. The computerized matching procedure included age, sex, body mass index, year of starting OSA treatment, treatment type, and duration selected 59 controls matched to 28 patients with BS. The main outcome was OSA treatment discontinuation within 2 years after BS. Patients with BS stopped OSA treatment more often than controls, usually between 6 months and 1 year after BS: hazards ratio (HR (95 %, CI)) 15.93 (3.29, 77.00). Before 6 months or beyond 1 year after BS, treatment discontinuation was not different between BS patients and controls. In univariate analyses, female gender, ...Continue Reading

References

Apr 1, 1993·The American Review of Respiratory Disease·N B KribbsD F Dinges
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·J L PépinP Lévy
Dec 21, 2000·JAMA : the Journal of the American Medical Association·P E PeppardJ Skatrud
Oct 14, 2004·JAMA : the Journal of the American Medical Association·Henry BuchwaldKaren Schoelles
Sep 15, 2005·Journal of Applied Physiology·Terry YoungShahrad Taheri
Feb 6, 2008·Proceedings of the American Thoracic Society·Naresh M Punjabi
Feb 6, 2008·Proceedings of the American Thoracic Society·Terri E Weaver, Ronald R Grunstein
Jun 3, 2009·The American Journal of Medicine·David L GreenburgArn H Eliasson
Jun 1, 2011·Sleep & Breathing = Schlaf & Atmung·Gláucia CarneiroSônia Maria Togeiro
Sep 20, 2011·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Jason J RasmussenMohamed R Ali
Feb 9, 2012·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·M J L RaveslootN de Vries
May 24, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Linda Schachter
Sep 26, 2012·Nature Reviews. Cardiology·Jean-Philippe BaguetJean-Louis Pépin
Jan 10, 2013·Obesity Surgery·Kourosh SarkhoshShahzeer Karmali
Jan 16, 2013·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Akram KhanBruce M Wolfe
Apr 10, 2013·Acta Cirúrgica Brasileira·José Maurício Lopes NetoSilke Anna Theresa Weber
May 22, 2013·PloS One·Jean Christian BorelUNKNOWN Scientific Council of The Sleep Registry of the French Federation of Pneumology (OSFP)
Aug 6, 2013·Lancet·Amy S JordanAtul Malhotra
Dec 4, 2014·European Journal of Internal Medicine·Andrew Kennedy-DalbyAkheel A Syed
Dec 18, 2014·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Jacob CollenArn Eliasson

❮ Previous
Next ❯

Citations

Apr 14, 2016·Obesity Surgery·Cristiana Rafaela Lopes da CruzAntonio Matias Esquinas Rodriguez
Jun 28, 2018·Obesity Surgery·Eric DeflandreBernard Bertrand

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.